InSet Technologies

InSet Technologies was a medical device company that specialized in the development and manufacture of innovative infusion sets for insulin pump therapy. The company's flagship product, the Inset infusion set, revolutionized the market by introducing an all-in-one design that integrated the infusion set with a built-in, disposable insertion device. This design significantly simplified the site-change process for patients with diabetes, improving ease of use and reducing the risk of needle-stick injuries. Following its acquisition by Unomedical in 2002, the technology became a cornerstone of the infusion set portfolios for major diabetes care companies, including Medtronic and Tandem Diabetes Care.